Yellow fever vaccine. V. Antibody response in maonkeys inoculated with graded doses of the 17D vaccine.

No abstract is available for this paper.

• Publication year

  1972

• Venue

  Applied microbiology

• Publication date

  1972-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AEM.23.5.908-913.1972PMID 4624211PMCID PMC380469
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Yellow Fever Vaccine. IV. Reactogenicity and Antibody Response in Volunteers Inoculated With a Vaccine Free From Contaminating Avian Leukosis Viruses

  1972cited by this paper
• Yellow Fever Vaccine. II. Antigenicity and Neurovirulence of a Vaccine Seed Free from Avian Leukosis Virus

  1969cited by this paper
• Yellow Fever Virus. II. Factors Affecting the Plaque Neutralization Test

  1969cited by this paper
• Yellow fever virus. I. Development and evaluation of a plaque neutralization test.

  1968cited by this paper
• Yellow Fever Vaccine I. Development of a Vaccine Seed Free from Contaminating Avian Leukosis Viruses

  1968cited by this paper
• A yellow fever vaccine free from avian leucosis viruses

  1967cited by this paper
• Protection Against Junin Virus by Immunization with Live Tacaribe Virus

  1965cited by this paper
• Application of a microtechnique to viral serological investigations.

  1962cited by this paper
• Effects of Medial Temporal Lesions on Taste Preference in the Monkey

  1960cited by this paper
• Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.

  1958cited by this paper
• PLAQUE FORMATION AND ISOLATION OF PURE LINES WITH POLIOMYELITIS VIRUSES

  1954cited by this paper

• Yellow Fever in Non-Human Primates: A Veterinary Guide from a One Health Perspective

  2025cites this paper
• New insights into an old vaccine: potency and breadth of neutralizing antibodies elicited by the yellow fever vaccine 17D are boosted by heterologous Orthoflavivirus infection

  2025cites this paper
• Safety and Immunogenicity of the Attenuated Yellow Fever Vaccine in Several Neotropical Primate Species

  2025cites this paper
• Safety and immunogenicity of different 17DD yellow fever vaccines in golden-headed tamarins (Leontopithecus chrysomelas): Inhibition of viremia and RNAemia after homologous live-attenuated vaccination.

  2025cites this paper
• Long-term immunity following yellow fever vaccination: a systematic review and meta-analysis.

  2024cites this paper
• Immunogenicity and duration of protection after yellow fever vaccine in people living with HIV: A systematic review.

  2021cites this paper
• Assessment of immunity against Yellow Fever virus infections in northeastern Nigeria using three serological assays

  2021cites this paper
• Safety and immunogenicity of 17DD attenuated yellow fever vaccine in howler monkeys (Alouatta spp.)

  2020cites this paper
• Minimal immune response to booster vaccination against Yellow Fever associated with pre-existing antibodies.

  2020cites this paper
• Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation

  2018cites this paper
• Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4

  2018cites this paper
• Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

  2013cites this paper
• Characterisation of the immune response after yellow fever vaccination

  2011cites this paper
• Antiviral Treatment of Flaviviruses

  2009cites this paper
• Yellow fever vaccine

  2005cites this paper
• Yellow fever vaccines.

  1997cites this paper
• Immune response in rabbits to virion and nonvirion antigens of the Flavivirus kunjin

  1977cites this paper
• Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D Vaccine

  1973cites this paper